Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes

被引:129
作者
Ogata, Kiyoyuki
Kishikawa, Yoshifumi
Satoh, Chikako
Tamura, Hideto
Dan, Kazuo
Hayashi, Akio
机构
[1] Nippon Med Coll, Inst Gerontol, Div Hematol, Tokyo 1138603, Japan
[2] Nippon Med Coll, Inst Gerontol, Dept Bioregulat, Tokyo 1138603, Japan
[3] Nippon Med Coll, Dept Med, Tokyo 1138603, Japan
[4] Mitsubishi Kagaku Bioclin Labs, Dept Res & Dev, Tokyo, Japan
关键词
D O I
10.1182/blood-2005-12-4916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis of myelodysplastic syndromes (MDS) without an increase in blasts and ringed sideroblasts (low-grade MDS without ringed sideroblasts [LGw/ oRS]) may be problematic because dysplastic features are not specific to MDS and approximately 50% of patients with LGw/oRS lack chromosomal aberrations. Here, we report the usefulness of flow cytometric characteristics of CD34(+) cells for LGw/oRS diagnosis. Bone marrow cells from LGw/oRS patients and controls (eg, cytopenic individuals without MDS) were analyzed using 4-color flow cytometry (FCM). We objectively determined reference ranges of 13 parameters related to CD34(+) cells with data from controls. In LGw/oRS; patients, various abnormalities of CD34(+) cells-eg, decrease in CD34(+) B-cell precursors, aberrant expression or overexpression of various antigens on CD34(+) myeloblasts-were observed. We constructed a reproducible, flow cytometric scoring system for LGw/oRS diagnosis. High scores were observed in 16 of 27 LGw/oRS patients, regardless of the presence or absence of chromosomal aberrations, but not in any of the 90 controls. Among LGw/oRS patients with chromosomal aberrations, patients with trisomy 8 or del20(q) had low FCM scores (P =.002). As a result, most LGw/oRS patients were identified based on high FCM score, chromosomal aberration, or both.
引用
收藏
页码:1037 / 1044
页数:8
相关论文
共 38 条
[21]   EFFECT OF TIME, TEMPERATURE, AND ANTICOAGULANT ON FLOW-CYTOMETRY AND HEMATOLOGICAL VALUES [J].
PAXTON, H ;
BENDELE, T .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 677 :440-443
[22]  
READING CL, 1993, BLOOD, V81, P3083
[23]   Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes [J].
Saitoh, K ;
Miura, I ;
Takahashi, N ;
Miura, AB .
BLOOD, 1998, 92 (08) :2886-2892
[24]   Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients [J].
SanMiguel, JF ;
Martinez, A ;
Macedo, A ;
Vidriales, MB ;
LopezBerges, C ;
Gonzalez, M ;
Cabaliero, D ;
GarciaMarcos, MA ;
Ramos, F ;
FernandezCalvo, J ;
Calmuntia, MJ ;
DiazMediavilla, J ;
Orfao, A .
BLOOD, 1997, 90 (06) :2465-2470
[25]   Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome [J].
Sloand, EM ;
Mainwaring, L ;
Fuhrer, M ;
Ramkissoon, S ;
Risitano, AM ;
Keyvanafar, K ;
Lu, J ;
Basu, A ;
Barrett, AJ ;
Young, NS .
BLOOD, 2005, 106 (03) :841-851
[26]  
Solé F, 2000, BRIT J HAEMATOL, V108, P346
[27]   Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? [J].
Steensma, DP ;
Dewald, GW ;
Hodnefield, JM ;
Tefferi, A ;
Hanson, CA .
LEUKEMIA RESEARCH, 2003, 27 (03) :235-242
[28]  
Stelzer GT, 1997, CYTOMETRY, V30, P214, DOI 10.1002/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO
[29]  
2-H
[30]   Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome [J].
Sternberg, A ;
Killick, S ;
Littlewood, T ;
Hatton, C ;
Peniket, A ;
Seidl, T ;
Soneji, S ;
Leach, J ;
Bowen, D ;
Chapman, C ;
Standen, G ;
Massey, E ;
Robinson, L ;
Vadher, B ;
Kaczmarski, R ;
Janmohammed, R ;
Clipsham, K ;
Carr, A ;
Vyas, P .
BLOOD, 2005, 106 (09) :2982-2991